Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 1504

Article ID: 698882

Study Reveals Broad ‘Genetic Architectures’ of Traits and Diseases

Johns Hopkins Bloomberg School of Public Health

Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases.

Released:
13-Aug-2018 11:55 AM EDT
8-13-18ChanapaSyringe_Spine_Anesthetic_iStock-134106302.jpg

Article ID: 698790

Surprise Finding: For Very Sick Elderly, Lighter Sedation Won’t Drop Risk of Postoperative Delirium, Study Suggests

Johns Hopkins Medicine

Johns Hopkins Medicine researchers say a study designed to see if reducing the amount of anesthesia reduces the risk of postoperative delirium in older patients surprisingly found that lighter sedation failed to do so in severely ill people undergoing hip fracture repair.

Released:
13-Aug-2018 8:00 AM EDT

Article ID: 698802

MD Anderson and Accelerator Life Science Partners Launch Magnolia Neurosciences to Speed Development of Neuroprotective Therapies

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding. The company will develop novel therapeutics based on discoveries made by researchers in MD Anderson’s Therapeutics Discovery division, including the Institute for Applied Cancer Science (IACS) and the Neurodegeneration Consortium (NDC).

Released:
13-Aug-2018 6:00 AM EDT
yacoubian14-3-3.jpg

Article ID: 698848

Study Identifies Chaperone Protein Implicated in Parkinson’s Disease

University of Alabama at Birmingham

Reduced levels of a chaperone protein might have implications for the development of Parkinson’s disease and Lewy body dementia, according to new research from UAB. Chaperone protein 14-3-3 could lead to misfolding and spread of alpha-synuclein.

Released:
10-Aug-2018 3:05 PM EDT
  • Embargo expired:
    9-Aug-2018 5:00 PM EDT

Article ID: 698522

Study Reveals High Rates of Dementia in Older Adults after Starting Dialysis

American Society of Nephrology (ASN)

• Older adults who initiate dialysis for kidney failure face a higher likelihood of being diagnosed with dementia and Alzheimer’s disease. • Certain risk factors were linked this higher risk. • Older hemodialysis patients with a diagnosis of dementia or Alzheimer’s disease had a high risk of early death.

Released:
3-Aug-2018 9:00 AM EDT

Article ID: 698774

Elderly Patients on Dialysis Have a High Risk of Dementia

Johns Hopkins Bloomberg School of Public Health

Older kidney disease patients who are sick enough to require the blood-filtering treatment known as dialysis are at high risk of dementia, including Alzheimer’s disease, according to a study led by scientists at Johns Hopkins Bloomberg School of Public Health.

Released:
9-Aug-2018 11:00 AM EDT

Article ID: 698734

Georgetown Study Investigates Memory Improvement Through Nicotine Dosing

Georgetown University Medical Center

A clinical trial being conducted at Georgetown explores if nicotine can slow or stop memory loss in people experiencing mild memory problems, or mild cognitive impairment (MCI).

Released:
9-Aug-2018 7:00 AM EDT
NerveCells_shutterstock_360993305.jpg

Article ID: 698753

Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases

University of South Australia

There is new hope for the treatment of Alzheimer’s and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.

Released:
9-Aug-2018 1:05 AM EDT

Article ID: 698731

Harrington Discovery Institute Announces New Scholars

University Hospitals Cleveland Medical Center

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio—part of The Harrington Project for Discovery & Development—has announced three new scholars in collaboration with its partners Foundation Fighting Blindness (FFB) and Alzheimer’s Drug Discovery Foundation (ADDF). Harrington Discovery Institute collaborates with FFB on the Gund-Harrington Award to accelerate therapies for retinal degenerative diseases and ADDF to advance the development of drugs to prevent and treat Alzheimer’s disease.

Released:
8-Aug-2018 3:05 PM EDT
Encalada6.jpg

Article ID: 698656

Researchers Look to Worms for a New Model of a Peripheral Nervous System Disease

Scripps Research Institute

"In humans, being able to tweak levels of TTR degradation could act as a means of stopping TTR toxicity."

Released:
7-Aug-2018 12:05 PM EDT

Showing results 2130 of 1504

Chat now!